Pyxis Oncology Inc (PYXS)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on Twitter

Get access to advanced features

Subscribe to better monitor insider activity

Stock chart

Ticker: PYXS Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value	Details
Sept. 28, 2023	Sept. 28, 2023	B Purchase	Connealy Pamela Ann CFO and COO Officer	8,000 +1.0% 1.87 14,960 USD	8,000 +1.0%	1.87	14,960 USD
Sept. 27, 2023	Sept. 27, 2023	B Purchase	Connealy Pamela Ann CFO and COO Officer	6,426 +0.8% 1.85 11,868 USD	6,426 +0.8%	1.85	11,868 USD
Sept. 27, 2023	Sept. 27, 2023	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	2,500 +1.1% 1.87 4,675 USD	2,500 +1.1%	1.87	4,675 USD
Sept. 25, 2023	Sept. 25, 2023	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	5,000 +2.3% 1.77 8,850 USD	5,000 +2.3%	1.77	8,850 USD
Sept. 25, 2023	Sept. 25, 2023	B Purchase	Connealy Pamela Ann CFO and COO Officer	12,000 +1.5% 1.67 20,044 USD	12,000 +1.5%	1.67	20,044 USD
Sept. 22, 2023	Sept. 22, 2023	B Purchase	Connealy Pamela Ann CFO and COO Officer	5,000 +0.6% 1.74 8,695 USD	5,000 +0.6%	1.74	8,695 USD
Sept. 22, 2023	Sept. 22, 2023	B Purchase	Wadhane Jitendra Chief Accounting Officer Officer	2,500 +1.2% 1.74 4,349 USD	2,500 +1.2%	1.74	4,349 USD
Sept. 18, 2023	Sept. 18, 2023	S Sale	Sullivan Lara President and CEO Executive Director	8,541 -0.4% 2.10 17,936 USD	8,541 -0.4%	2.10	17,936 USD
Sept. 18, 2023	Sept. 14, 2023	S Sale	Sullivan Lara President and CEO Executive Director	100 -0.0% 2.25 225 USD	100 -0.0%	2.25	225 USD
Sept. 13, 2023	Sept. 13, 2023	S Sale	Sullivan Lara President and CEO Executive Director	3,000 -0.1% 2.27 6,816 USD	3,000 -0.1%	2.27	6,816 USD
Sept. 13, 2023	Sept. 12, 2023	S Sale	Sullivan Lara President and CEO Executive Director	4,917 -0.2% 2.25 11,071 USD	4,917 -0.2%	2.25	11,071 USD
Sept. 13, 2023	Sept. 11, 2023	S Sale	Sullivan Lara President and CEO Executive Director	20,000 -0.8% 2.27 45,414 USD	20,000 -0.8%	2.27	45,414 USD
March 21, 2023	March 17, 2023	B Purchase	PFIZER INC Major owner	1,811,594 +43.8% 2.76 4,999,999 USD	1,811,594 +43.8%	2.76	4,999,999 USD
April 25, 2022	April 21, 2022	S Sale	Chin Mark Former Director	1,745,761 -100.0% 3.05 5,324,571 USD	1,745,761 -100.0%	3.05	5,324,571 USD
Dec. 9, 2021	Dec. 8, 2021	B Purchase	Cline Darren S Non-Executive Director	10,000 +inf% 9.39 93,885 USD	10,000 +inf%	9.39	93,885 USD
Nov. 19, 2021	Nov. 18, 2021	B Purchase	Civik Thomas Non-Executive Director	15,700 +inf% 12.74 200,018 USD	15,700 +inf%	12.74	200,018 USD
Oct. 15, 2021	Oct. 13, 2021	B Purchase	Chin Mark Non-Executive Director	312,500 +21.8% 16.00 5,000,000 USD	312,500 +21.8%	16.00	5,000,000 USD
Oct. 15, 2021	Oct. 13, 2021	B Purchase	Cormorant Asset Management, LP	450,000 +67.3% 16.00 7,200,000 USD	450,000 +67.3%	16.00	7,200,000 USD